Alvotech - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALVO Nasdaq 2830 www.alvotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alvotech

Alvotech (ALVO): 10 Penny Stocks With Explosive Growth Potential - Jun 20th, 2026 11:27 am
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement - Jun 18th, 2026 3:51 am
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares - Jun 18th, 2026 2:00 am
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Fed Policy Meeting - Jun 16th, 2026 6:34 am
Alvotech Prices Share Offering, Private Placement - Jun 16th, 2026 2:11 am
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement - Jun 15th, 2026 9:59 pm
Alvotech Launches Public Offering, Private Placement of Ordinary Shares - Jun 15th, 2026 2:28 pm
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions - Jun 10th, 2026 1:02 pm
Alvotech shares jump after FDA accepts Entyvio biosimilar application for review (ALVO) - Jun 8th, 2026 4:41 am
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio® - Jun 8th, 2026 2:00 am
How The Investment Story For Alvotech (ALVO) Is Shifting Without New Analyst Guidance - Jun 6th, 2026 8:12 pm
Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection - Jun 6th, 2026 9:44 am
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - Jun 5th, 2026 11:31 am
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End - Jun 4th, 2026 10:02 pm
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea® - Jun 4th, 2026 2:00 am
Alvotech to present at upcoming investor conferences in June - Jun 2nd, 2026 2:30 pm
Alvotech (ALVO) Q4 2025 Earnings Transcript - Jun 2nd, 2026 11:17 am
Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland - Jun 1st, 2026 2:30 am
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End - May 13th, 2026 6:13 pm
Alvotech announces completion of FDA surveillance inspection at Reykjavik facility - May 11th, 2026 2:30 am